Presenilin-1 mutations and Alzheimer's disease

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):629-631. doi: 10.1073/pnas.1619574114. Epub 2017 Jan 12.

Authors

Raymond J Kelleher 3rd^{1

2}, Jie Shen^{3

4}

Affiliations

¹ Department of Neurology, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
² Program in Neuroscience, Harvard Medical School, Boston, MA 02115.
³ Program in Neuroscience, Harvard Medical School, Boston, MA 02115; jshen@rics.bwh.harvard.edu.
⁴ Department of Neurology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease*
Amyloid beta-Protein Precursor / genetics
Humans
Mutation
Presenilin-1*
Presenilin-2

Substances

Amyloid beta-Protein Precursor
Presenilin-1
Presenilin-2

Grants and funding